Chronic Disease Reviews

Introduction

A chronic disease review is a planned, structured consultation for a patient with a long-term condition, distinct from an opportunistic or acute-problem consultation. Its purpose is to check disease control against agreed targets, screen proactively for complications before they cause symptoms, review medication appropriateness, and support the patient's own self-management - all in a single, organised contact rather than piecemeal across multiple unrelated visits.

Structured review is a defining feature of UK primary care's approach to chronic disease and is heavily shaped by the Quality and Outcomes Framework (QOF), a pay-for-performance scheme that rewards practices for maintaining disease registers and delivering evidence-based review indicators for conditions including diabetes, COPD, asthma, hypertension, atrial fibrillation, heart failure, chronic kidney disease, epilepsy and severe mental illness.¹

This model matters for exams as much as for practice, because a large share of UKMLA-style questions about long-term conditions are really questions about the review process itself: what should be checked, how often, and what should trigger a change of plan - rather than purely about diagnosing the condition in the first place.

How registers and recall work

Practices maintain disease registers - coded lists of patients with each long-term condition - built from diagnostic codes entered at any contact (primary care, hospital discharge letters, clinic letters). Patients on a register are proactively invited for review, typically annually, rather than relying on the patient to remember or request one.

• Recall systems generate invitations by post, text or app in advance of when a review is due, often bundling bloods and other pre-review tests so results are available at the appointment
• Skew towards non-attenders: patients who do not respond to invitations are disproportionately those with the least engagement and often the highest risk - practices increasingly use targeted follow-up (phone calls, opportunistic review at other appointments) for this group
• Newly diagnosed patients are added promptly so that early review and education are not missed

Structure of an effective review

A well-run review follows a consistent structure regardless of the specific disease, adapted to the condition's own targets and complications.

1. Ask what matters to the patient and how the condition is affecting their day-to-day life, not only how the numbers look
2. Review symptom control and functional impact since the last review
3. Check disease-specific metrics against agreed targets (for example HbA1c, blood pressure, spirometry)
4. Screen for complications relevant to that condition, even in the absence of symptoms
5. Review medication: adherence, side effects, interactions, and whether the regimen still matches current guidance
6. Reinforce self-management: inhaler technique, foot care, blood glucose monitoring, action plans as relevant
7. Agree and document a plan, including what the patient will do themselves and when the next review is

Worked example: the diabetes annual review

The Type 2 diabetes review is the best-known example of a structured chronic disease review and illustrates the general pattern, following the stepwise assessment and treatment pathway set out in NICE NG28.³

Equivalent structured reviews exist for other conditions - for example, COPD review, per NICE NG115, covers symptom burden (using a validated tool such as the CAT score), exacerbation frequency, inhaler technique, smoking status, vaccination and pulmonary rehabilitation referral;⁴ asthma review covers control (using the Royal College of Physicians' 3 Questions or a validated score), inhaler technique, adherence and exacerbation history.

Foot risk stratification in diabetes

This stratification, generated at each annual foot check, determines how frequently a patient is seen between annual reviews - a low-risk result is not a reason to stop checking altogether, since risk category can change with disease progression.

Combined reviews and multimorbidity

A patient with several long-term conditions historically might be invited to a separate annual review for each one - a substantial burden in itself. Modern practice increasingly favours combined reviews, addressing overlapping conditions (for example diabetes, hypertension and chronic kidney disease share several relevant tests) in a single appointment, consistent with the multimorbidity-aware, patient-priority approach described in NICE NG56.²

Structured medication review

A structured medication review is an explicit component of chronic disease review, particularly for patients on multiple regular medicines. Increasingly delivered by clinical pharmacists working within general practice, it covers indication, effectiveness, safety (interactions, monitoring requirements), and patient experience of taking the medication, and is a key vehicle for deprescribing where appropriate.

Where a review identifies a medicine that may no longer be needed, or where a target has been achieved and a drug could reasonably be stepped down, this should be raised and, where agreed, actioned - a review that only ever adds medication, never removes it, is a recognised failure mode.

A useful discipline is to treat every chronic disease review as an opportunity to ask 'is there anything on this list we could stop, as well as anything we should start' - reviewing the full medication list against current indications, not just the drugs specific to the condition being reviewed that day, since a diabetes review is often the only structured point of contact where a patient's whole regimen is looked at together.

Self-management support

Structured education and self-management support are consistently shown to improve outcomes and are a core, examinable component of chronic disease care, not an optional extra.

• Structured education programmes: DESMOND or DAFNE for diabetes, pulmonary rehabilitation for COPD, cardiac rehabilitation post-MI
• Self-monitoring: blood glucose or flash glucose monitoring in diabetes, peak flow diaries in asthma, home blood pressure monitoring in hypertension
• Written action plans: personalised asthma action plans, COPD self-management (rescue pack) plans
• Signposting to condition-specific charities and support groups, and to social prescribing where broader support is needed

Reviews beyond the classic long-term conditions

The same structured-review logic extends to groups whose reviews are less about a single measurable target and more about proactively catching problems that would otherwise go unaddressed.

Severe mental illness physical health checks

People with severe mental illness (schizophrenia, bipolar disorder, and other psychotic illnesses) have substantially reduced life expectancy compared with the general population, driven largely by preventable physical health conditions rather than the mental illness itself - cardiovascular disease especially, compounded by antipsychotic-related weight gain, dyslipidaemia and diabetes risk, smoking, and reduced engagement with routine healthcare. An annual physical health check - weight/BMI, blood pressure, glucose/HbA1c, lipids, and specific screening for antipsychotic side effects - is a QOF-incentivised, proactive counterbalance to this gap in care, and should be offered assertively rather than left for the patient to request.

Learning disability annual health checks

People with a learning disability similarly experience worse physical health outcomes and are less likely to have health problems identified early through routine means, partly due to communication barriers and 'diagnostic overshadowing' - attributing a new physical symptom to the learning disability itself rather than investigating it. An annual health check, ideally using an accessible, easy-read health action plan, is designed specifically to counter this pattern, covering general health, medication review, and any condition-specific screening relevant to the individual.

Barriers to effective review

Structured review is only as good as the system that delivers it, and several recurring barriers limit its real-world effectiveness even where the clinical template itself is sound.

• Non-attendance, particularly in patients with the highest risk or greatest social deprivation
• Reviews reduced to a tick-box exercise focused on QOF targets rather than the patient's actual priorities
• Fragmented care across multiple specialists with no one taking an overview
• Time pressure limiting the depth of medication review and self-management discussion
• Digital exclusion where recall and results rely on text or app-based systems
• Language or literacy barriers reducing the effectiveness of written self-management materials and action plans
• Review templates completed for coding/QOF purposes without a genuine conversation happening alongside the data entry

Addressing non-attendance actively - rather than simply re-sending the same letter - matters disproportionately, since the patients who do not attend are often those at highest risk of an unrecognised deteriorating condition. Practical measures include phone calls in addition to text/letter reminders, offering flexible appointment times, opportunistic review when a non-attender is seen for an unrelated reason, and outreach via community pharmacy or home visiting teams for patients who are housebound.

Red flags

Why it matters

Structured review is one of the reasons UK primary care achieves comparatively good population-level control of conditions like diabetes and hypertension: proactive recall catches deteriorating control and emerging complications before they present as an emergency, and consistent complication screening (retinal photography, foot assessment, renal monitoring) detects treatable early disease that would otherwise be missed between symptomatic presentations.

The evidence base for individual elements - tight blood pressure control, early nephropathy detection, structured education - is strong; the review itself is simply the delivery mechanism that ensures those interventions actually reach patients on a predictable schedule rather than opportunistically. Where that delivery mechanism breaks down - through non-attendance, fragmented care, or a review reduced to box-ticking - the underlying evidence-based interventions do not reach the patients who need them, however sound the guidance behind them is.